Twist Bioscience Corp short interest in 2020
In 2020, Twist Bioscience Corp's disclosed short interest ran from 13.28% of shares outstanding on 15 Apr 2020 to 5.63% on 31 Dec 2020, a change of -7.65 percentage points. The year's high was 13.28% on 15 Apr 2020 and its low 5.63% on 31 Dec 2020, averaging 10.02% across 18 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.59 days on 31 Jul 2020. Full history: Twist Bioscience Corp.
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2020 in figures
- Start of year
- 13.28% (15 Apr 2020)
- End of year
- 5.63% (31 Dec 2020)
- Change
- -7.65 pp
- High
- 13.28% (15 Apr 2020)
- Low
- 5.63% (31 Dec 2020)
- Average
- 10.02%
- Highest days to cover
- 12.59 (31 Jul 2020)
- SEC filings marked
- 8
Every report in 2020
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Apr 2020 | 13.28% | 11.22 | results (8-K), 10-Q filed |
| 30 Apr 2020 | 12.73% | 12.38 | |
| 15 May 2020 | 10.38% | 9.86 | results (8-K), 10-Q filed |
| 29 May 2020 | 10.53% | 11.61 | |
| 15 Jun 2020 | 10.28% | 5.87 | |
| 30 Jun 2020 | 11.77% | 8.64 | |
| 15 Jul 2020 | 11.97% | 11.38 | |
| 31 Jul 2020 | 11.74% | 12.59 | |
| 14 Aug 2020 | 10.74% | 7.88 | results (8-K), 10-Q filed |
| 31 Aug 2020 | 9.41% | 10.69 | |
| 15 Sep 2020 | 9.89% | 8.89 | |
| 30 Sep 2020 | 9.74% | 6.64 | |
| 15 Oct 2020 | 9.58% | 8.09 | |
| 30 Oct 2020 | 8.88% | 7.80 | |
| 13 Nov 2020 | 9.09% | 8.46 | |
| 30 Nov 2020 | 8.16% | 7.68 | results (8-K), 10-K filed |
| 15 Dec 2020 | 6.53% | 3.61 | |
| 31 Dec 2020 | 5.63% | 3.51 |
See also: Twist Bioscience Corp's full history · most shorted US stocks of 2020 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.